Behind Closed Doors: Inside the Investment Committee
From a founder's seat, the fundraising process can feel like a sequence of coffee chats, a deck review, and eventually an email.
From a founder's seat, the fundraising process can feel like a sequence of coffee chats, a deck review, and eventually an email. But on the investor side, especially once a deal reaches the Investment Committee the mechanics are far more layered, and almost entirely invisible to the outside.
An IC doesn't just ask, "Is this a good company?" It simultaneously asks: "Does this deal break our fund math?" "Are we spending GP bandwidth in the right place?" "Does the risk-return profile hold up against the rest of the portfolio?"
This is why "a great company" and "the right investment for this fund right now" are often two very different things and when founders don't internalize that gap, a pass can feel personal when it rarely is.
Below, we try to pull back the curtain on how an IC actually thinks, what it's measuring at each stage, and what signals move a deal forward or kill it. The goal is simple: make both sides of the table better at this.
1. Deal Entry: What Actually Happens When a Startup Comes In
When a deal arrives whether from a warm intro, an inbound, or a sourcing push, the first filter is usually an investment analyst or a Partner doing a quick read. The pitch deck matters, but what's not in it matters just as much. We're pressure-testing the core claim: Is the thesis sharp? Is the data durable? Is the business model scalable? Does it fit the fund's mandate?
Most deals don't make it past this stage. A pass here is not a signal of disinterest in the company. It's usually a signal of mandate mismatch. Only deals with a credible fit against our investment thesis ever reach the full committee. That makes this the most consequential and least visible gate in the entire process.
Deals that clear the initial screen move into partner-level engagement. Before anything goes to IC, most or all partners will have had direct exposure to the founders, sometimes a formal session, sometimes a dinner, sometimes something more informal. We're not just stress-testing the idea; we're assessing the founders. Technical depth of the founding team, go-to-market capability, fundraising maturity, domain expertise, early traction, coachability, and a credible path to a fundable exit, all of that gets shaped here.
Founder takeaways:
Before your first touchpoint with any fund, understand its thesis and portfolio construction. Lead with strategic fit — not just the pitch. The right question to answer is: "Why is this fund the right partner for us at this stage?
If there are gaps in technical depth or domain expertise on your team, don't paper over them. Acknowledge them and articulate a specific plan to close them. Investors diligence everything, gaps are less damaging than the sense that founders aren't honest about them.
Treat partner meetings as mutual diligence, not a pitch performance. How you think, how you listen, and how you handle pressure will be evaluated as seriously as your deck. Nobody wants to be locked into a 7-year relationship with someone they don't trust or enjoy working with. That's true for both sides.
Investors (IC Members) takeaways:
At the screening stage, a brief, honest note explaining a pass strengthens the ecosystem even if it's one sentence. Founders improve; good relationships compound.
Front-loading partner touchpoints before IC significantly increases the probability that deals reaching the committee are actually investable.
Instead of filtering for a "perfect team" upfront, filter against your fund's specific deal-killers. It's faster and reduces false negatives.
2. The Analyst Review: Defensibility Over Technical Elegance
Investment analysts aren't trying to understand whether a model works. They're trying to understand why it matters. Data source continuity matters as much as model accuracy. Before bringing a deal to a Partner, an analyst is looking for defensible answers to a core set of questions:
– Can competitors replicate access to the same data set?
– How durable is the moat and under what conditions does it erode?
– Is this a product, or a compounding system? Does it get harder to displace as it scales?
– Does the data advantage hold across geographies, or is it structurally local?
– If a well-funded competitor enters with a comparable approach, does this company still win? On what basis?
– If a large strategic copies the core feature tomorrow, what's actually left?
In most deals, it's the absence of clean answers to these questions, not technical weakness that causes a deal to stall. Early-stage investors aren't looking for technical depth; they're looking for a credible, defensible competitive position.
There's a sharp distinction between workflow-heavy, easily replicable solutions and businesses with genuine domain lock-in and steep learning curves. Technology that commoditizes execution is often a liability at the investment stage. The analyst review also looks forward: where does this product sit in 12–24 months, not just today?
Founder takeaways:
Have a direct, honest answer prepared for "How long before a well-resourced competitor replicates this?" Evasion here is a red flag.
Show the flywheel concretely: how does the product get harder to displace the more it's used? Specific customer examples beat abstract claims.
Investors (IC Members) takeaways:
Lead with "Why does this company win?" — not "How does it work?"
Be deliberate about separating workflow businesses from deeply-moated domain plays. The investment thesis is different for each.
3. Partner Conviction: The Invisible Gate
For a deal to reach the IC, it must have a champion. A Partner who isn't just presenting it, but actively backing it. Every deal that gets to committee has someone at the table who is prepared to own it. If no partner is willing to say "I'll sponsor this," the deal is effectively dead before it reaches the room.
Founders often read a fade in engagement as "they lost interest." What actually happened is that no partner internalized the deal well enough to defend it against the fund's mandate and the IC's scrutiny. No partner will go to bat for a deal they don't believe in, or that they can't make a credible case for relative to the portfolio thesis. No champion = no committee.
Partner conviction almost never forms in a single meeting. Partners want to see a founder across contexts, a product conversation, a market debate, an informal dinner. They're not just assessing the idea; they're assessing judgment, intellectual honesty, and communication under pressure. The deal that goes to IC is one a partner has already stress-tested privately.
Founder takeaways:
Don't compress the partner relationship into a single pitch. Think of it as a distributed diligence process running in parallel with your own. Spread the touchpoints.
If engagement drops off, ask directly: "Is there a specific concern I can address?" Partners respect directness. It's also useful information either way.
Authenticity outperforms polish at the partner stage. Be yourself. The partners will work with you for years — they're not just buying the pitch, they're buying the working relationship.
Investors (IC Members) takeaways:
Don't put a deal on the IC agenda unless you're prepared to own the outcome, in either direction.
Expand founder touchpoints beyond the formal pitch — different contexts reveal different things.
4. Partner Meetings and Q&A: The Stress Test
Partner sessions are less a presentation format and more an intensive Q&A designed to stress-test both the business and the founder. The canonical questions "Why now?", "Why this market?" "Why you?" get asked multiple times, often in the same words. That's not poor preparation on our part; it's intentional. We want to see if the answers are consistent under pressure, and whether the founder is working from deep conviction or a rehearsed narrative.
What the IC faces post-investment board dynamics, competitive pivots, down rounds, team departures, is orders of magnitude harder than any partner meeting. So at this stage, how a founder answers matters more than what they answer. Does criticism trigger defensiveness or curiosity? Is market and product command genuine, or surface-level? How does the founder handle an unexpected angle they haven't prepared for?
These sessions also test for learning velocity. A founder who can say "We haven't thought about it that way, let me work through that" is a stronger signal than a founder who has a polished answer for everything. Over-confidence and rehearsed certainty often read as a risk flag, not a green one. Partners are looking for someone who is ready to navigate the unknowns — not just narrate the knowns.
Founder takeaways:
“I don't know" is a legitimate answer — use it deliberately rather than deflecting. The bar isn't omniscience; it's intellectual honesty and learning agility.
Rather than defending, walk us through your decision-making framework. How you think is more fundable than any single answer.
Show genuine ownership of the market and product with specific, textured examples. First-principles depth reads very differently from pitch-deck familiarity.
Investors (IC Members) takeaways:
Score reflexes and consistency, not just the content of answers.
Ask the same question across different sessions and see if the thinking holds.
The goal is to understand the founder, not to find a reason to pass.
5. Deep Dive: Where the Story Meets the Numbers
At the deep dive stage, the pitch narrative recedes and the actual business is on the table. Architecture decisions, CAC mechanics, churn drivers, unit economics at scale. These get examined directly, not through a deck. For most founders, this is their first real exposure to institutional-grade due diligence, and it's almost always harder than expected.
The IC isn't looking for perfection at this stage. It's looking for internal consistency. Numbers don't need to be flawless, but they need to hold together. If one metric contradicts another, that's a signal. Problems that have been papered over almost always surface here. That's why the process slows down at this stage and why the most consequential IC judgments usually form here, not in the pitch.
The deep dive also reveals how deeply the founder owns the business. As questions go deeper, rehearsed answers run out quickly and genuine command of the material shows through. "We haven't solved this yet, but here's our current hypothesis" is almost always more credible than a vague deflection. On the investor side, we're not looking for a clean cap table and polished metrics, we're trying to understand where the risk lives, how it's being managed, and whether the team is genuinely equipped to face it.
Founder takeaways:
Frame problems rather than hiding them. "Here's the issue, here's why it exists, here's how we're managing it" is more fundable than a gap that surfaces mid-diligence.
Be explicit about why metrics are at their current level. Context makes a number meaningful; the absence of context makes it a red flag.
"We haven't solved this yet" is a legitimate answer — but it needs to be followed by a credible plan, not a shrug.
Investors (IC Members) takeaways:
Evaluate numbers in context, not in isolation. A single metric without its surrounding system rarely tells you much.
Where you see inconsistency, go deeper — that's almost always where the real risk is sitting.
The goal is to see the risk clearly and early — not to find a reason to pass. Some risks are worth taking.
6. Valuation, IRR, and Portfolio Construction
Founders anchor on valuation. The IC anchors on fund math. These are not the same conversation.
Here's the baseline: a $100M fund typically targets 3–4x net returns to LPs over a 10-year life. That implies roughly 20–25% IRR at the fund level. But the power law is brutal: most portfolio companies will return little or nothing. For the fund to work, a small number of companies need to return 20–30x, sometimes more. This is why the IC question is "What's the return multiple potential here?" not "What's the valuation?" Valuation is one input into that calculation. If the potential multiple doesn't clear the fund's threshold, the narrative doesn't matter.
Entering at 10% for $2M on a $20M post-money means the company needs to exit at $400–600M+ for this investment to meaningfully move the fund. A "clean" exit at $100–150M may be a genuine success for the founder. It's usually not fund-returning.
This is why exit probability, exit pathway, and exit timing are live IC conversations from the first meeting, not post-term-sheet housekeeping. "This could be big" is not enough. We need a credible answer to how, with whom, on what timeline, and why the strategic or financial logic holds.
Founder takeaways:
Before defending a valuation, be explicit about your return multiple thesis. What does the math look like at different exit sizes? Work through it out loud.
Understand the difference between a "good outcome for founders" and a "fund-returning outcome." Both can be true, but the IC is optimizing for the latter.
Talk about exit as probability-weighted scenario analysis, not aspiration. "We think the most likely acquirer is X, at a Y multiple, in a Z-year window" is a fundable conversation.
Investors (IC Members) takeaways:
Put IRR scenarios on the table concretely — not as a target, but as a set of outcomes tied to specific assumptions.
Before passing on valuation grounds, run the fund-level impact analysis. Sometimes the math works better than it looks.
Mid-range exits can quietly distort portfolio dynamics. Be deliberate about how many "good but not great" outcomes you can absorb.
7. Unicorn Scenarios, M&A, and IPO Realities
Unicorn status isn't a romantic aspiration in an IC, it's a probability-weighted calculation. The more operative question at the table is: even if this company doesn't hit unicorn scale, can it generate a fund-returning exit?
M&A scenarios are live from early diligence and they're not built purely from what the founder tells us. The IC independently tracks comparable transactions, acquirer behavior in the sector, and consolidation dynamics. "Who buys this company?" is a critical question. "Why would they?" is just as important. Revenue alone isn't an M&A thesis. The acquirer needs to be getting something that accelerates their roadmap, extends their moat, or consolidates a competitive threat. ARR without strategic rationale rarely drives premium multiples.
One thing many founders miss: when a VC fund invests, it's a time-boxed partnership. Most funds operate on a 7–12 year lifecycle. When the fund winds down, it has to return capital to LPs which means every investment needs a realization path. The IC keeps this constraint in view at every stage: "At what point, and under what conditions, does this investment return capital, and how much?"
A company running $10M ARR isn't automatically M&A-ready. At 5–8x ARR a common range for strategic acquirers. That's a $50–80M exit. That's a strong outcome for the founder. For most institutional funds, it doesn't move the needle. The math needs to work at scale for both sides of the table.
On the IPO path: the filter isn't growth. It's recurring revenue quality, margin structure, and the coherence of the long-term narrative for public market investors. The IC asks not "Can this IPO?" but "Under what conditions, at what scale, and within what timeline does this generate a fundable liquidity event?"
Founder takeaways:
Understand the fund's lifecycle — when is it likely to need liquidity? That shapes how your exit timeline looks from the GP's perspective.
Build a real M&A thesis: who are the likely strategic acquirers, what problem does an acquisition solve for them, and what's the buyer-side math? Don't deflect this question.
Frame exit as scenario analysis with explicit assumptions — multiple, timing, pathway — not as a vision statement.
Investors (IC Members) takeaways:
When you say yes to entry terms, be equally explicit about your exit thesis — how and when you expect to generate returns.
Don't limit M&A and IPO analysis to what the founder tells you. Build an independent view from market data, comparable transactions, and acquirer motivation.
Always run both questions: "Is this a good outcome for the founder?" and "Is this a fund-returning outcome?" They're not the same.
8. Decision Mechanics, Red Flags, and Closing Thoughts
IC decision mechanics vary by fund. Some operate on majority vote, others require consensus. Alignment and genuine enthusiasm within the partnership matter beyond the formal threshold. In consensus funds, a single skeptical partner creates a real challenge, one that can cut either way. It doesn't mean the company is bad; it usually means the partnership hasn't yet resolved how it thinks about the risk profile.
At this stage, behavioral red flags are often more determinative than technical ones:
– Claims without supporting data
– Dismissing competitive risk without genuine engagement
– Deflecting or externalizing past failures
– Communication patterns that signal poor future board dynamics
Technology shifts. Markets evolve. Character doesn't change much. Founder assessment isn't limited to the pitch. It includes reference calls, team dynamics observed during office visits, how someone handles adversarial questions in real time, and how they communicate under operational pressure. All of it feeds the picture.
The IC is often framed by founders as an obstacle. A more useful frame: it's a mirror. The right questions, pressure-tested honestly, give founders a clearer picture of their own business regardless of the outcome. A good IC surfaces the risks the founder hasn't seen yet. A good founder uses those questions to think more clearly, not to prepare better rebuttals.
The clearest version of what the IC is ultimately evaluating: not just whether this is a good company, but whether the people carrying it have what it takes to go the distance. Long-term winners are the founders who understand this dynamic early and engage with it rather than fighting it.
Founder takeaways:
Treat the IC as a diagnostic tool, not an adversary. The process is designed to find the weak points in your thesis — that's valuable information regardless of the outcome.
How you behave in this process is being evaluated as much as what you say. Consistency under pressure is a fundable signal.
Engage with criticism as a signal, not noise. Founders who update in real time are exactly who we want to back.
Investors (IC Members) takeaways:
Align on decision mechanics and risk appetite within the partnership before a deal gets to the table.
Don't let behavioral red flags get rationalized away by strong technical metrics. The signals are usually right.
Better questions lead to better investments. That's the whole job.